XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $197 | -18.6% | 105,743 | +14.1% | 0.00% | – |
| Q2 2023 | $242 | +5.7% | 92,703 | -33.7% | 0.00% | – |
| Q1 2023 | $229 | +59.0% | 139,732 | +29.0% | 0.00% | – |
| Q4 2022 | $144 | -99.8% | 108,311 | +78.3% | 0.00% | – |
| Q3 2022 | $95,000 | +106.5% | 60,745 | +105.3% | 0.00% | – |
| Q2 2022 | $46,000 | -17.9% | 29,594 | +35.8% | 0.00% | – |
| Q1 2022 | $56,000 | – | 21,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $9,843,616 | 24.86% |
| Stonepine Capital Management, LLC | 8,640,205 | $14,083,534 | 4.72% |
| Alpine Global Management, LLC | 400,000 | $652,000 | 0.25% |
| DELTEC ASSET MANAGEMENT LLC | 622,072 | $1,013,977 | 0.25% |
| XTX Topco Ltd | 233,385 | $380,418 | 0.08% |
| Redmile Group, LLC | 1,046,587 | $1,705,937 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 316,025 | $515 | 0.05% |
| Yakira Capital Management, Inc. | 90,076 | $146,824 | 0.04% |
| IHT Wealth Management, LLC | 281,442 | $458,762 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 960,111 | $1,565 | 0.02% |